These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Life with cytostatic drugs. Van Dam FS, Linssen AC, Engelsman E, van Benthem J, Hanewald GJ. Eur J Cancer (1965); 1980; Suppl 1():229-33. PubMed ID: 6947892 [No Abstract] [Full Text] [Related]
7. Three cases of toxic skin eruptions associated with methotrexate and a compilation of methotrexate-induced skin eruptions. Scheinfeld N. Dermatol Online J; 2006 Dec 10; 12(7):15. PubMed ID: 17459301 [Abstract] [Full Text] [Related]
8. Dermatologic changes after systemic cancer therapy. Nixon DW, Pirozzi D, York RM, Black M, Lawson DH. Cutis; 1981 Feb 10; 27(2):181-2, 186-8, 192-4. PubMed ID: 6164518 [Abstract] [Full Text] [Related]
17. Alkaline comet assay study with breast cancer patients: evaluation of baseline and chemotherapy-induced DNA damage in non-target cells. Kopjar N, Milas I, Garaj-Vrhovac V, Gamulin M. Clin Exp Med; 2006 Dec 10; 6(4):177-90. PubMed ID: 17191110 [Abstract] [Full Text] [Related]
19. A clinical study of fluorouracil. Nadler SH, Moore GE. Surg Gynecol Obstet; 1968 Dec 10; 127(6):1210-4. PubMed ID: 4882472 [No Abstract] [Full Text] [Related]
20. Cyclophosphamide, methotrexate, and 5-FU (CMF)-induced nausea and vomiting: a controlled study with high-dose metoclopramide. David M, Durand M, Chauvergne J, Mauriac L, Bui BN, Hoerni B. Cancer Treat Rep; 1984 Jun 10; 68(6):921-2. PubMed ID: 6547368 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]